Quality & complianceOfficial

Production problems disrupt Danish supply of Elanco's AviPro IBD LC-75 veterinary vaccine

🇩🇰 DKMA · Thu 05 Nov 2026

The Danish Medicines Agency says supply of Elanco's live attenuated infectious bursal disease vaccine is expected to be disrupted from late September to mid-December 2026.

The Danish Medicines Agency (DKMA) has published a supply notice for AviPro IBD LC-75 Vet., a lyophilisate for use in drinking water marketed in Denmark by Elanco Denmark ApS. The notice was first posted on 24 September 2026 and updated on 5 November 2026.

According to the agency, the cause is production problems. The disruption is expected to run from the end of September to mid-December 2026. The notice gives no further technical detail on the manufacturing issue.

The product contains live, attenuated infectious bursitis virus, strain LC-75, and carries the ATC vet code QI01AD09. Infectious bursitis is also known as infectious bursal disease, a poultry disease.

DKMA does not name alternative products or set out any mitigation measures in the notice. It directs anyone with questions about the current status to contact Elanco Denmark ApS directly.

What it means for your team

  • Regulatory and supply teams handling veterinary products in Denmark should check the DKMA supply notice for updates, as the notice has already been revised once.
  • The expected disruption window runs to mid-December 2026; the agency's notice does not say whether supply will resume on that date.
  • Questions about current availability should go to Elanco Denmark ApS, as DKMA's notice does not give status details.
  • No alternatives or substitution arrangements are identified in the notice.

Official source: DKMA ↗

Article written by VigiEye from the official source (DKMA). AI-assisted; check the source before acting.

More Quality & compliance All →